The optimization of the vaccines roll-out using GS1 Standards in Ireland, New-Zealand and Turkey.
Senior executives discussed their work about developing a verification system in digital healthcare to reduce the risk from falsified and diverted COVID-19 vaccines.
- Suzanne Mc Donald: Deloitte Ireland Consulting Partner – Health & Social Care Lead
- Dr Peter Stevens: GS1 New-Zealand CEO
- Shiobain Duggan: GS1 Ireland Director of Innovation & Healthcare
- Ozgur Yilmaz Gomec: VISIOTT - Head of Sales & Business Developments